Business Wire | 19 days 9 hours 4 minutes ago
Alkermes’ Corporate Presentation to be Webcast at the Credit Suisse Healthcare Conference
Nov 04, 2009 3:00 PM CST
CAMBRIDGE, Mass.-- (BUSINESS WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Credit Suisse on Wednesday, November 11, 2009, at 5:00 p.m. MT (7:00 p.m. ET) from the Arizona Biltmore Hotel in Phoenix, Arizona. The presentation may be accessed under the investor relations tab at www.alkermes.com. The presentation will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.
Alkermes, Inc.
Eva Stroynowski, 617-583-6823
Corporate
Communications
Articles appearing above are picked up from Business Wire's feed. Stories from this feed are submitted by companies, edited and rereleased as a service of Business Wire.
Sign up for FDLI SmartBrief
Companies mentioned